06/01/2026 14:30
UBS lowered the target price for JD Health (06618) to HKD78 from HKD85 and maintained the "buy" rating.
The research house said it expects revenue growth in Q425 to be stronger than the company's previous guidance (low-teens %).
【你點睇?】美軍出兵、台海升溫、中美角力...一開年就咁多黑天鵝,你而家係加倉定現金為王?入嚟vote! ► ► 立即投票
上一篇新聞︰06/01/2026 16:05 {I-bank focus}Morgan raises China Oilfield to HKD9.22
下一篇新聞︰05/01/2026 16:03 {I-bank focus}Daiwa lowers Mixue Group (02097) to HKD427
08/01/2026 14:45 {I-bank focus}Citi lowers TG Smart Energy (01083) to HKD4
07/01/2026 16:05 {I-bank focus}Morgan raises CTG Duty-Free (01880) to HKD89
07/01/2026 14:37 {I-bank focus}J.P. Morgan raises CIMC Enric (03899) to HKD12
05/01/2026 14:40 {I-bank focus}Citi raises Chow Tai Fook (01929) to HKD18.2
02/01/2026 16:02 {I-bank focus}HSBC raises CMOC (03993) to HKD18.6
